Clinical Trial Update: The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 trial in patients with chronic hepatitis C examined changes in myeloid-derived suppressor cells and natural killer cell activity during direct-act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Direct-acting antivirals (DAAs)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Chronic Hepatitis C | EARLY_Phase 1 | Status: COMPLETED